Michael Davis

Michael Davis, Ph.D. is a senior scientist with significant experience in the field of cancer biology and immunology. With a background in RNA vaccines and tumor suppressors, Michael has made key contributions in understanding innate immune pathways in response to infections like SARS-CoV-2 and developing treatments for melanoma. Michael's research has focused on elucidating cellular mechanisms driving cell death and inflammation, with a strong academic foundation from Vanderbilt University and extensive work experience at research institutions like the Fred Hutchinson Cancer Research Center and the University of Washington.